Interestingly, when excluding patients with PVS from the group of patients with CHD, the prevalence of intragenic in-frame mutation was similar (9/39, 23.1%) to that observed in NF1 patients without CHD (89/420, 21.2%) (p > 0.05). This evidence concerns the gene NF1 and coronary artery disorder.